Thu, Nov 13, 2025
A A A
Welcome Guest
Free Trial RSS pod
Get FREE trial access to our award winning publications
Industry Updates

Edgewater Capital Partners teams up with CBCC Global Research

Thursday, May 29, 2025
Opalesque Industry Update - Edgewater Capital Partners, a Cleveland, Ohio-based private equity firm, has partnered with the shareholders and management team of CBCC Global Research, a multi-national clinical contract research organization with deep experience in designing and managing clinical trials across a range of critical therapeutic areas, including oncology, CNS, and ophthalmology. Based in Bakersfield, California with additional operations in Ahmedabad, India, CBCC Global Research provides end-to-end clinical CRO services - spanning clinical study design, trial recruitment and site management, biostatistics and data analysis, regulatory strategy and medical writing - across Phase I-IV clinical trials.

"We are excited to begin this next stage of our growth with Edgewater," said Manoj Vyas, CEO of CBCC Global Research. "We share a mutual vision on how to continue developing CBCC Global Research into a leading partner for our clients within our focused therapeutic areas. Edgewater's willingness to invest in top people, technology, and infrastructure, combined with their deep understanding of the life sciences and clinical development landscape, makes them the ideal partner for CBCC Global Research's next stage of growth."

"CBCC Global Research has earned a reputation as a trusted partner in the pharmaceutical development ecosystem, distinguished by their deep therapeutic area experience and unwavering commitment to customer support, quality and regulatory excellence," said Pete Ostergard, Managing Partner at Edgewater. "Our investment reflects our belief in the strength of their leadership, differentiated clinical trial capabilities, and multi-national infrastructure and site network. We look forward to building on CBCC Global Research's momentum."

Calfee, Halter, & Griswold LLP served as legal counsel to Edgewater Capital Partners. Western & Southern Financial Group provided debt financing for the transaction. Edgemont Capital Partners served as CBCC Global Research's exclusive financial advisor. Stradling Yocca Carlson & Rauth LLP served as legal counsel to CBCC Global Research.

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Previous Opalesque Exclusives                                  
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Global fintech investment slumps to seven-year low of $95.6bn[more]

    Laxman Pai, Opalesque Asia: Global fintech investment plummeted to $95.6 billion across 4,639 deals in 2024, marking its lowest level since 2017, as investors grappled with persistent macroeconomic challenges and geopolitical tensions, revealed a study. According to the Pulse of Fintech H2'

  2. Opalesque Exclusive: Private capital deal value climbed 19% in 2024[more]

    Bailey McCann, Opalesque New York: Private capital deal value climbed 19% in 2024, according to the latest data from the Global Private Capital Association. Growth was driven by big-ticket investments across Southeast Asia, Latin America and Central & Eastern Europe (CEE). Investor confidence

  3. Opalesque Roundup: Citco: 77% of hedge funds achieved positive returns in January 2025: hedge fund news[more]

    In the week ending February 21st, 2025, a report revealed that hedge funds enjoyed one of their best opening months this decade in January, as Equity and Multi-Strategy funds posted strong returns. Funds administered by the Citco group of companies (Citco) delivered a weighted average return of 4%,

  4. Opalesque exclusive: Permuto's new equity unbundling product to change investment model[more]

    Opalesque Geneva for New Managers: Here is a different way of owning stocks coming to you soon: the option of holding just the dividend portion of a stock, independent of its price movements. Or capturing the stock&

  5. Opalesque Exclusive: Hedge funds outperform mutual funds in managing extreme risk contagion - key insights for investors[more]

    Matthias Knab, Opalesque for New Managers: Hedge funds and mutual funds are among the most prominent vehicles for investors seeking growth and diversification. However, a critical question persists: which fund ty